文献速递免疫规划卫生政策与健康促进传染病防控与疫情报告

中华人民共和国疫苗可预防疾病控制:1949-2016

Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
PubMed 文献 · Vaccine · 2018-11-26

该研究回顾中国1950至2016年免疫规划档案与监测数据,并访谈专家,梳理疫苗可预防疾病控制历程。结果显示,随着农村合作医疗建立、冷链系统完善及2004年后中央财政投入增加,多数疫苗可预防疾病发病率大幅下降,消灭脊髓灰质炎并于2000年获认证,2006年后无白喉报告。

要点

  • 20世纪70年代农村合作医疗与培训卫生员使白喉、百日咳、脊灰、麻疹、乙脑发病率显著下降。
  • 1980年代冷链系统建立使白喉、百日咳、麻疹、流脑发病率降幅超90%。
  • 2004年后中央加大公共卫生投入,2011-2016年麻疹发病率<2.0/10万,百日咳等<0.2/10万。

核心结论

  • 长期政治承诺、宏大目标、以疾病发病率为评估指标及全国推广本地优化策略是中国控制疫苗可预防疾病的关键。

研究设计与样本

  • 综述性研究:回顾国家和省级卫生部门档案,分析1950至2016年疾病监测、疫苗接种覆盖率和血清学调查数据,并对早期参与疫苗可预防疾病控制的中国资深专家进行深度访谈。

主要发现

  • 1980至1989年,白喉、百日咳、麻疹和流脑发病率下降超90%,脊灰和乙脑下降40-50%。
  • 2011至2016年,每10万人口发病率麻疹<2.0,百日咳、乙脑、流脑和甲肝<0.2。
  • 1992至2014年,5岁以下儿童慢性乙肝感染率从9.7%降至0.3%,降幅97%。
  • 中国于2000年获无脊灰认证,2006年为最后报告白喉病例年份。

临床怎么用

  • 应坚持将免疫接种作为基本权利的政治承诺,设定宏大目标并以疾病发病率作为项目绩效评估的主要指标。
  • 全国推广本地开发的优化有限资源的成功策略,如冬季“突击接力”运输系统和冷链系统建设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: China's immunization program is one of the oldest and largest in the world. Rates of vaccine-preventable diseases (VPD) are comparable to those in high-income countries. The program's evolution has been characterized by ambitious target setting and innovative strategies that have not been widely described. METHODS: We reviewed national and provincial health department archives; analyzed disease surveillance, vaccination coverage, and serosurvey data from 1950 through 2016; and, conducted in-depth interviews with senior Chinese experts involved early VPD control efforts. RESULTS: Widespread immunization began in the 1950s with smallpox, diphtheria, and Bacillus-Calmette Guerin vaccines, and in the 1960s with pertussis, tetanus, polio, measles, and Japanese encephalitis (JE) vaccines. The largest drops in absolute VPD burden occurred in the 1970s with establishment of the Rural Cooperative Medical System and a cadre of trained peasant health workers whose responsibilities included vaccinations. From 1970 to 1979, incidence per 100,000 population dropped 48% from 3.3 to 1.75 for diphtheria, 50% from 152.2 to 49.4 for pertussis, 77% from 2.5 to 0.6 for polio, 60% from 450.5 to 178.3 for measles, and 72% from 18.0 to 5.1 for JE, averting an average of 4 million VPD cases each year. Until the early 1980s, vaccines were delivered through annual winter campaigns using a coordinated 'rush-relay' system to expedite transport while leveraging vaccine thermostability. Establishment of the cold chain system during in the 1980s allowed bi-monthly vaccination rounds and more timely vaccination resulting in rates of diphtheria, pertussis, measles and meningitis falling over 90% from 1980 to 1989, while polio and JE rates fell 40-50%. In the 1990s, progress stalled as financing for public health was weakened by broad market reforms. Large investments in public health and immunizations by the central government since 2004 has led to further declines in VPD burden and increased equity. During 2011-2016, the incidence per 100,000 population was <2.0 for measles and <0.2 for pertussis, JE, meningococcal meningitis, and hepatitis A. From 1992 to 2014, the prevalence of chronic hepatitis B infection in children <5 years fell from 9.7% to 0.3%, a 97% decline. China was certified polio-free in 2000 and diphtheria was last reported in 2006. CONCLUSIONS: Long-term political commitment to immunizations as a basic right, ambitious targets, use of disease incidence as the primary metric to assess program performance, and nationwide scale-up of successful locally developed strategies that optimized use of available limited resources have been critical to China's success in controlling vaccine-preventable diseases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yu W, Lee LA, Liu Y, et al. Vaccine-preventable disease control in the People's Republic of China: 1949-2016. Vaccine. 2018. PMID: 30497834. doi:10.1016/j.vaccine.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。